Navigation Links
Feynman's double-slit experiment brought to life
Date:3/13/2013

The precise methodology of Richard Feynman's famous double-slit thought-experiment a cornerstone of quantum mechanics that showed how electrons behave as both a particle and a wave has been followed in full for the very first time.

Although the particle-wave duality of electrons has been demonstrated in a number of different ways since Feynman popularised the idea in 1965, none of the experiments have managed to fully replicate the methodology set out in Volume 3 of Feynman's famous Lectures on Physics.

"The technology to do this experiment has been around for about two decades; however, to do a nice data recording of electrons takes some serious effort and has taken us three years," said lead author of the study Professor Herman Batelaan from the University of Nebraska-Lincoln.

"Previous double-slit experiments have successfully demonstrated the mysterious properties of electrons, but none have done so using Feynman's methodology, specifically the opening and closing of both slits at will and the ability to detect electrons one at a time.

"Akira Tonomura's brilliant experiment used a thin, charged wire to split electrons and bring them back together again, instead of two slits in a wall which was proposed by Feynman. To the best of my knowledge, the experiments by Guilio Pozzi were the first to use nano-fabricated slits in a wall; however, the slits were covered up by stuffing them with material so could not be open and closed automatically."

In their experiments, which have been published today, Thursday 14 March, in the Institute of Physics and German Physical Society's New Journal of Physics, Batelaan and his team, along with colleagues at the Perimeter Institute of Theoretical Physics, created a modern representation of Feynman's experiment by directing an electron beam, capable of firing individual electrons, at a wall made of a gold-coated silicon membrane.

The wall had two 62-nm-wide slits
'/>"/>

Contact: Michael Bishop
michael.bishop@iop.org
01-179-301-032
Institute of Physics
Source:Eurekalert

Page: 1 2

Related biology technology :

1. Florida Tech Research Team Earns Competitive Grant, Begins ISS Mission Biology Experiment
2. Invisible tool enables new quantum experiments
3. First experiment at the ALBA synchrotron
4. ORNL experiments prove nanoscale metallic conductivity in ferroelectrics
5. U of Toronto experiment named top breakthrough of 2011 by Physics World
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22 de enero de 2015  El Dr. Paul ... llamada a nominaciones para 2015. Este prestigioso premio reconoce ... tiene el potencial para hacer, contribuciones destacadas para la ... hasta el 15 de marzo de 2015 a través ...
(Date:1/22/2015)... 22, 2015   GenoSpace , a precision medicine software company ... the broad use of genomic, imaging and other biomedical data ... Michelle Munson , CEO of Aspera, an IBM Company, ... - http://photos.prnewswire.com/prnh/20150122/170713 "We are pleased ...
(Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
(Date:12/24/2014)... BOTHELL, Wash. , Dec. 24, 2014   BioLife Solutions ... manufacturer and marketer of proprietary clinical grade hypothermic storage ... thermal shipping products for cells and tissues  ("BioLife" or ... Annual Meeting of Stockholders on May 4, 2015 (the "Annual ...
Breaking Biology Technology:El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4GenoSpace Expands Board with Appointment of Michelle Munson 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4BioLife Solutions Sets Date for Annual Meeting of Stockholders 2
... will be one of the presenters at Digestive Disease ... in interventional gastroenterologyORANGEBURG, S.C., May 29 Zeus, Inc., ... it has been invited to present at Digestive Disease ... Dr. Bruce Anneaux, Ph.D. and GI Endoscopy Specialist Aubrey ...
... May 29 Dey L.P., a subsidiary of Mylan ... it has begun to market and distribute EMSAM(R) in ... monoamine oxidase inhibitor (MAOI), which was approved by the ... the treatment of major depressive disorder. EMSAM previously was ...
... have designed cells that can count and "remember" cellular events, ... activated in a specific order. , Such circuits, which mimic ... the number of times a cell divides, or to study ... biosensors that count exposures to different toxins. , The team ...
Cached Biology Technology:Zeus to Present at Digestive Disease Week in Chicago 2Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder 2MIT, BU engineer cellular circuits that count events 2MIT, BU engineer cellular circuits that count events 3
(Date:1/22/2015)... , Jan. 22, 2015 Infinisource has launched its new ... G2 model. The G2 sets a higher standard for collecting ... capital management solution. With plug-and-play installation, touch screen interface and ... provides a robust time collection solution for the small to ...
(Date:12/22/2014)... 22, 2014  The 2014 Holiday Season may be the ... Intelligence reports that the long anticipated floodgates for consumer ... demand for smart phones, tablets, and wearable mobile devices ... 2.5 billion users with nearly 4.8 billion biometric devices ...
(Date:12/19/2014)... Dec. 18, 2014   LaunchKey , the first decentralized ... and Internet of Things era, today announced the close ... round was led by Metamorphic Ventures with participation from ... VegasTechFund, and others.  LaunchKey has raised $4 million to ...
Breaking Biology News(10 mins):Infinisource's NXG series sets new time clock standard 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3
... University School of Medicine studies of Hispanic farmworkers in North ... had skin disease and that workers need more information about ... deadly diseases such as skin cancer. , Few studies have ... Wake Forest studies, 59 farmworkers from Nash and Johnston Counties ...
... most effective chemotherapy drugs against cancer is cisplatin because ... it also kills healthy tissue. Many scientists are creating ... treatments without side effects. One approach to analog development ... a Virginia Tech chemistry-biology research team that has been ...
... ensure complete tumor removal at breast cancer excision is ... used light waves in a newly explored region of ... and determine if the removed tissue margins were clear ... potential to eliminate the need for multiple surgeries and ...
Cached Biology News:Skin disease common among Hispanic farmworkers in North Carolina, research shows 2Light activated anticancer drug targeted to DNA using cisplatin like sub-units 2Terahertz imaging may reduce breast cancer surgeries 2
Human RXR beta/NR2B2 MAb (Clone H7341) Keywords: RXRbeta, RXRbeta, Retinoid X Receptor beta...
Human SOST Affinity Purified Polyclonal Ab...
BOND ELUT MATRIX-C18, 25 mg ...
Prepared from plasminogen by activation with immobilized human uPA...
Biology Products: